Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Circulating tumor DNA (ctDNA) minimal residual disease (MRD) is a robust biomarker with the potential to improve survival outcomes for Non-small-cell lung cancer (NSCLC)
When considering all post-treatment follow-up time points (surveillance), including those beyond the initial post-treatment measurement, these assays’ performances improve with sensitivity and specificity for identifying relapse ranging from 82% to 100% and 70% to 100%, respectively.
…